Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
JUNSthis companyJupiter Neurosciences, Inc.	$2.29	-4.08×	-19.28×	1,620.54×	-4.3×	-239.6%	80.6%	-40873.2%	-39662.8%	471.9%	-255.4%	-15.3%	-2.9×	-0.18×	-134.94×	0.65×	0.0%	3	-23.07	2	C
ABVCABVC BioPharma, Inc.	$0.98	-5.46×	4.46×	0×	-7.04×	-109.1%	0.0%	0.0%	0.0%	-71.2%	-42.6%	-6.0%	0.31×	-0.38×	-17.2×	0.41×	0.0%	1	-5.28	1	C-
ALGSAligos Therapeutics, Inc.	$4.54	-3.8×	1.72×	42.14×	-3.45×	-97.4%	57.5%	-4024.9%	-1106.7%	-45.2%	-123.9%	-90.0%	0.1×	0.57×	0×	3.9×	0.0%	2	-16.11	2	C
GRCEGrace Therapeutics, Inc.	$1.93	-9.85×	1.2×	0×	-5.37×	-60.9%	0.0%	0.0%	0.0%	-12.2%	-14.1%	-11.6%	0×	1.53×	0×	8.1×	0.0%	2	5.07	2	C+
SERSerina Therapeutics, Inc.	$1.53	-1×	-526.02×	0×	-0.88×	-94.7%	0.0%	0.0%	0.0%	51843.2%	-709.0%	-92.3%	-5.3×	0.15×	-112.78×	1.71×	0.0%	2	-3.55	2	C+
SKYESkye Bioscience, Inc.	$0.92	-0.53×	1.49×	0×	-0.44×	-40.6%	0.0%	0.0%	0.0%	-279.3%	-286.6%	-144.8%	0.01×	0.1×	0×	3.3×	0.0%	1	-41.52	2	C+
Peer median	—	-3.8×	1.49×	0×	-3.45×	-94.7%	0.0%	0.0%	0.0%	-45.2%	-123.9%	-90.0%	0.01×	0.15×	0×	3.3×	0.0%	2	-5.28	2	—